In last trading session, Silexion Therapeutics Corp (NASDAQ:SLXN) saw 0.31 million shares changing hands with its beta currently measuring 0.09. Company’s recent per share price
Silexion Therapeutics Corp (NASDAQ:SLXN)’s traded shares stood at 0.31 million during the last session, with the company’s beta value hitting 0.06. At the close of
In the last trading session, 8.51 million Silexion Therapeutics Corp (NASDAQ:SLXN) shares changed hands as the company’s beta touched -0.06. With the company’s per share
In last trading session, Silexion Therapeutics Corp (NASDAQ:SLXN) saw 0.43 million shares changing hands with its beta currently measuring -0.09. Company’s recent per share price
In today’s recent session, 74.05 million shares of the Silexion Therapeutics Corp (NASDAQ:SLXN) have been traded, and its beta is 0.08. Most recently the company’s
Silexion Therapeutics Corp (NASDAQ:SLXN)’s traded shares stood at 0.63 million during the last session, with the company’s beta value hitting 0.16. At the close of
Silexion Therapeutics Corp (NASDAQ:SLXN)’s traded shares stood at 1.31 million during the last session, with the company’s beta value hitting 0.10. At the close of
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
